Cell therapies are among the most promising, yet complex medicines being developed today. Multiply Labs' mission is to make these therapies more widely available by increasing manufacturing efficiency ...

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...

Robotic biomanufacturing company Multiply Labs said it has made a significant advance toward its goal of scaling production of cell and gene therapies by using Nvidia’s open Isaac and GR00T robotics ...

Traditional processes used to discover new materials are complex, time-consuming, and costly, often requiring years of sustained effort. Recent advances in large language models (LLMs) have ...

International experts will gather at WHX Labs in Dubai to address the forces shaping the next generation of laboratory leadership With AI and automation accelerating change, experts will examine how ...

SANTA CLARA, CA / ACCESS Newswire / February 4, 2026 / Expert Intelligence™, a startup building AI systems that automate expert decision-making in regulated laboratory environments, today announced it ...

Feb 6 (Reuters) - Goldman Sachs (GS.N), opens new tab is working with technology startup Anthropic to develop AI-powered agents aimed at automating a widening range of internal functions, CNBC ...